SCHEMBL12091

SCHEMBL12091

Cc1noc(-c2ccccc2)c1C(O)CCCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
TDP1 Q9NUW8 2/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
BRD4 O60885 3/20 0.38
MAPK1 P28482 1/20 0.38
BRD2 P25440 2/20 0.37
BRD3 Q15059 1/20 0.37
GAA P10253 1/20 0.37
LPAR1 Q92633 1/20 0.37
LPAR3 Q9UBY5 1/20 0.37
FAAH O00519 3/20 0.36
STAT3 P40763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838 0.91 L3MBTL1 (0.40) TSHRL3MBTL1TDP1ATMALDH1A1
SCHEMBL7480 0.87 LPAR1 (0.50) TSHRL3MBTL1TDP1ATMALDH1A1
SCHEMBL6888 0.87 FFAR1 (0.47) TSHRSMN1; SMN2MAPK1LPAR1LPAR3
SCHEMBL7241 0.85 LIPG (0.44) TSHRRAB9AFAAH
SCHEMBL6689 0.84 LIPG (0.43) TSHRL3MBTL1TDP1ATMBRD4
SCHEMBL7249 0.84 PPARG (0.51) TSHRL3MBTL1TDP1ATMBRD4
SCHEMBL6800 0.84 RAB9A (0.45) TSHRL3MBTL1TDP1ATMALDH1A1
SCHEMBL1596 0.84 LPAR1 (0.52) TSHRL3MBTL1TDP1ATMALDH1A1
SCHEMBL18597722 0.84 LPAR1 (0.37) TSHRL3MBTL1TDP1ATMALDH1A1
SCHEMBL6548 0.83 PTGER4 (0.47) TSHRLPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed